Resultados de la búsqueda 81-90 of 4230 for weakened immune system

  1. Alkaline phosphatase (ALP) blood test - Mayo Clinic

    It may be done if a standard ALP test result comes back too high or too low. ... weak. An ALP test is not used to diagnose weak, brittle bones, a condition ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...

  3. Hepatic encephalopathy

    A buildup of toxins affects the brain's ability to function. If left untreated or not treated successfully, hepatic encephalopathy can lead to unresponsiveness, ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated with pathologic ...

  5. Cirugía - Ensayos clínicos - Mayo Clinic

    The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated with pathologic ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

  8. Cirugía - Ensayos clínicos - Mayo Clinic

    Investigating the Link Between Type 2 Immunity ... affects its appearance and function and ultimately insulin resistance. ... A Study of Blood Clotting Response in ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The PD-1/PD-L1 cascade allows tumors to evade the immune system by suppressing T cell function within the TME. [5, 6] An ideal adoptive cellular therapy ...

  10. Hematología - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...